Polymorphisms of Human Leukocyte Antigen B*27 on Clinical Phenotype of Spondyloarthritis in Chinese
Overview
Biotechnology
Pathology
Affiliations
Background: In recent years, an ever-increasing number of alleles of human leukocyte antigen B*27 (HLA-B*27) have been identified. This study aimed to establish an updated method for HLA-B*27 subtyping, and to investigate the impact of HLA-B*27 polymorphisms on the clinical phenotype of spondyloarthritis (SpA).
Methods: Overall, 184 SpA patients were recruited for analyzing diversity of HLA-B*27 via an updated high-resolution polymerase chain reaction amplification with sequence specific primers (PCR-SSP).
Results: The prevalence of HLA-B*27 was 94.0%, and four subtypes were identified including HLA-B*2704 (77.5%), B*2705 (20.2%), B*2707 (1.7%), and B*2724 (0.6%). There was an obvious male predominance (P=.05) and markedly elevated C-reaction protein (CRP) in B*27 positive SpA (P<.01). In multivariate linear regression analysis, the elevated CRP was positively associated with HLA-B*27 positivity (regression coefficient B=46.1, P=.0003), grade of sacroiliitis (B=47.5, P=.0032), and male gender (B=20.4, P=.0041). Notably, a male predilection was also found in B*2705 positive SpA while B*2707 was associated with older age, higher positive family history, and higher prevalence of extra-articular features (all P<.05).
Conclusions: In this study, an updated PCR-SSP technique to identify increasing alleles of HLA-B*27 was developed and their different effects on clinical manifestations of SpA were demonstrated. Genotyping of HLA-B*27 would shed light on our understanding of the pathogenesis of SpA.
Sarcopenia and Variation in the Human Leukocyte Antigen Complex.
Jones G, Pilling L, Kuo C, Kuchel G, Ferrucci L, Melzer D J Gerontol A Biol Sci Med Sci. 2019; 75(2):301-308.
PMID: 30772894 PMC: 7176057. DOI: 10.1093/gerona/glz042.
Polymorphisms of human leukocyte antigen B*27 on clinical phenotype of spondyloarthritis in Chinese.
Ma H, Yin Q, Liu Y, Wu Y, Zhu T, Guo M J Clin Lab Anal. 2017; 32(2).
PMID: 28632339 PMC: 6816982. DOI: 10.1002/jcla.22275.